Annovis Bio Statistics
Share Statistics
Annovis Bio has 19.49M
shares outstanding. The number of shares has increased by 74.43%
in one year.
| Shares Outstanding | 19.49M |
| Shares Change (YoY) | 74.43% |
| Shares Change (QoQ) | 41.23% |
| Owned by Institutions (%) | 12.15% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 609 |
| FTD / Avg. Volume | 0.12% |
Short Selling Information
The latest short interest is 1.74M, so 8.95% of the outstanding
shares have been sold short.
| Short Interest | 1.74M |
| Short % of Shares Out | 8.95% |
| Short % of Float | 10.46% |
| Short Ratio (days to cover) | 8.22 |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | -0.89 |
| PS Ratio | 0 |
| Forward PS | 0.4 |
| PB Ratio | 0.01 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Annovis Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2718.87,
with a Debt / Equity ratio of 0.
| Current Ratio | 2718.87 |
| Quick Ratio | 2718.87 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-3,073,796,875 |
| Employee Count | 8 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -24.57B |
| Effective Tax Rate | 99.9% |
Stock Price Statistics
The stock price has increased by -71.01% in the
last 52 weeks. The beta is 1.51, so Annovis Bio's
price volatility has been higher than the market average.
| Beta | 1.51 |
| 52-Week Price Change | -71.01% |
| 50-Day Moving Average | 1.61 |
| 200-Day Moving Average | 5.82 |
| Relative Strength Index (RSI) | 51.46 |
| Average Volume (20 Days) | 502,265 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | n/a |
| Net Income | -24.59B |
| EBITDA | -22.74M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -2018.5 |
Full Income StatementBalance Sheet
The company has 10.55M in cash and 0 in
debt, giving a net cash position of 10.55M.
| Cash & Cash Equivalents | 10.55M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -134.85B |
| Total Assets | 13.93M |
| Working Capital | 10.04M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -21.89B
and capital expenditures 0, giving a free cash flow of -21.89B.
| Operating Cash Flow | -21.89B |
| Capital Expenditures | n/a |
| Free Cash Flow | -21.89B |
| FCF Per Share | -1797.22 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
